Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.

Allison SL, Koscik RL, Cary RP, Jonaitis EM, Rowley HA, Chin NA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Bendlin BB, Johnson SC.

Neuroimage Clin. 2019 Jun 10;23:101895. doi: 10.1016/j.nicl.2019.101895. [Epub ahead of print]

2.

Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum.

Allison SL, Rodebaugh TL, Johnston C, Fagan AM, Morris JC, Head D.

Arch Clin Neuropsychol. 2019 Jun 14. pii: acz019. doi: 10.1093/arclin/acz019. [Epub ahead of print]

PMID:
31197326
3.

Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study.

Koscik RL, Norton DL, Allison SL, Jonaitis EM, Clark LR, Mueller KD, Hermann BP, Engelman CD, Gleason CE, Sager MA, Chappell RJ, Johnson SC.

J Int Neuropsychol Soc. 2019 Feb;25(2):119-133. doi: 10.1017/S1355617718000954. Epub 2018 Dec 7.

4.

Longitudinal Standards for Mid-life Cognitive Performance: Identifying Abnormal Within-Person Changes in the Wisconsin Registry for Alzheimer's Prevention.

Koscik RL, Jonaitis EM, Clark LR, Mueller KD, Allison SL, Gleason CE, Chappell RJ, Hermann BP, Johnson SC.

J Int Neuropsychol Soc. 2019 Jan;25(1):1-14. doi: 10.1017/S1355617718000929. Epub 2018 Nov 28.

5.

Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife.

Clark LR, Koscik RL, Allison SL, Berman SE, Norton D, Carlsson CM, Betthauser TJ, Bendlin BB, Christian BT, Chin NA, Asthana S, Johnson SC.

Alzheimers Dement. 2019 Mar;15(3):418-428. doi: 10.1016/j.jalz.2018.09.008. Epub 2018 Oct 25.

PMID:
30367828
6.

Calcitonin Stewardship Strategies.

Allison SL, Davis KW 2nd.

J Pharm Pract. 2018 Jan 1:897190018770052. doi: 10.1177/0897190018770052. [Epub ahead of print]

PMID:
29661063
7.

Spatial Navigation in Preclinical Alzheimer's Disease.

Allison SL, Fagan AM, Morris JC, Head D.

J Alzheimers Dis. 2016 Feb 9;52(1):77-90. doi: 10.3233/JAD-150855.

8.

The entry machinery of flaviviruses.

Heinz FX, Stiasny K, Allison SL.

Arch Virol Suppl. 2004;(18):133-7. Review.

PMID:
15119768
9.

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation.

Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA.

EMBO J. 2004 Feb 25;23(4):728-38. Epub 2004 Feb 12.

10.

Mimicking live flavivirus immunization with a noninfectious RNA vaccine.

Kofler RM, Aberle JH, Aberle SW, Allison SL, Heinz FX, Mandl CW.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1951-6. Epub 2004 Feb 9.

11.

Flavivirus structure and membrane fusion.

Heinz FX, Allison SL.

Adv Virus Res. 2003;59:63-97. Review. No abstract available.

PMID:
14696327
12.

Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Allison SL, Tao YJ, O'Riordain G, Mandl CW, Harrison SC, Heinz FX.

J Virol. 2003 Nov;77(21):11357-66.

13.

Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line.

Gehrke R, Ecker M, Aberle SW, Allison SL, Heinz FX, Mandl CW.

J Virol. 2003 Aug;77(16):8924-33.

14.

Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus.

Kroschewski H, Allison SL, Heinz FX, Mandl CW.

Virology. 2003 Mar 30;308(1):92-100.

15.

Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus.

Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, Helenius A.

J Virol. 2003 Apr;77(7):4370-82.

16.

Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus.

Elshuber S, Allison SL, Heinz FX, Mandl CW.

J Gen Virol. 2003 Jan;84(Pt 1):183-91.

PMID:
12533715
17.
18.

Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH.

Stiasny K, Allison SL, Schalich J, Heinz FX.

J Virol. 2002 Apr;76(8):3784-90.

19.

The machinery for flavivirus fusion with host cell membranes.

Heinz FX, Allison SL.

Curr Opin Microbiol. 2001 Aug;4(4):450-5. Review.

PMID:
11495810
20.

Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus.

Ferlenghi I, Clarke M, Ruttan T, Allison SL, Schalich J, Heinz FX, Harrison SC, Rey FA, Fuller SD.

Mol Cell. 2001 Mar;7(3):593-602.

21.

Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus.

Stiasny K, Allison SL, Mandl CW, Heinz FX.

J Virol. 2001 Aug;75(16):7392-8.

22.
23.

Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX.

J Virol. 2001 May;75(9):4268-75.

24.

Structures and mechanisms in flavivirus fusion.

Heinz FX, Allison SL.

Adv Virus Res. 2000;55:231-69. Review. No abstract available.

PMID:
11050944
25.
26.

Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system.

Corver J, Ortiz A, Allison SL, Schalich J, Heinz FX, Wilschut J.

Virology. 2000 Mar 30;269(1):37-46.

27.

A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.

Aberle JH, Aberle SW, Allison SL, Stiasny K, Ecker M, Mandl CW, Berger R, Heinz FX.

J Immunol. 1999 Dec 15;163(12):6756-61.

28.

Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.

Allison SL, Stiasny K, Stadler K, Mandl CW, Heinz FX.

J Virol. 1999 Jul;73(7):5605-12.

29.

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia.

Ecker M, Allison SL, Meixner T, Heinz FX.

J Gen Virol. 1999 Jan;80 ( Pt 1):179-85.

PMID:
9934700
30.

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model.

Mandl CW, Aberle JH, Aberle SW, Holzmann H, Allison SL, Heinz FX.

Nat Med. 1998 Dec;4(12):1438-40.

PMID:
9846585
31.
32.

Proteolytic activation of tick-borne encephalitis virus by furin.

Stadler K, Allison SL, Schalich J, Heinz FX.

J Virol. 1997 Nov;71(11):8475-81.

33.

Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus.

Stiasny K, Allison SL, Marchler-Bauer A, Kunz C, Heinz FX.

J Virol. 1996 Nov;70(11):8142-7.

34.
35.

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis.

Heinz FX, Allison SL, Stiasny K, Schalich J, Holzmann H, Mandl CW, Kunz C.

Vaccine. 1995 Dec;13(17):1636-42.

PMID:
8719513
36.

Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.

Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX.

J Virol. 1995 Sep;69(9):5816-20.

37.

Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.

Allison SL, Schalich J, Stiasny K, Mandl CW, Kunz C, Heinz FX.

J Virol. 1995 Feb;69(2):695-700.

38.
39.

Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM.

Heinz FX, Stiasny K, Püschner-Auer G, Holzmann H, Allison SL, Mandl CW, Kunz C.

Virology. 1994 Jan;198(1):109-17.

PMID:
8259646
40.
41.

Supplemental Content

Loading ...
Support Center